humanized antibody

未知生产厂商

专利

每项发明一条，涵盖美国、欧洲、PCT 与中国的同族专利。

Method of treating cancer including administering a human chimeric antibody specific for the ganglioside GD3
US 7045129 B2申请人: KYOWA HAKKO KOGYO KK优先权: 2001
US
9 件公开
RI-LABELED HUMANIZED ANTIBODY
EP 4049684 A4申请人: NIHON MEDIPHYSICS CO LTD优先权: 2019
CN
EP
US
WO
8 件公开
HUMANIZED C-KIT ANTIBODY
EP 3453724 A1申请人: AMGEN INC优先权: 2006
CN
EP
US
8 件公开
HUMANIZED ANTI-HUMAN-PD-1 ANTIBODY
EP 3883966 B1申请人: OSE IMMUNOTHERAPEUTICS优先权: 2018
EP
US
WO
8 件公开
HUMANIZED ANTIBODY
- US 2009093002 A1
  申请人: GENENTECH INC优先权: 2007
  US
  7 件公开
- US 2005226883 A1
  申请人: AVERBACK PAUL优先权: 2004
  CN
  US
  3 件公开
- CN 105169388 A
  申请人: GENENTECH INC优先权: 2007
  CN
  US
  2 件公开
- US 7456260 B2
  申请人: US HEALTH优先权: 2004
  US
- US 2010297012 A1
  申请人: PFEIFER ANDREA优先权: 2008
  US
HUMANIZED ANTI-DNAM-1 ANTIBODY
EP 4450627 A4申请人: UNIV TSUKUBA优先权: 2021
CN
EP
US
WO
6 件公开
ANTI-IGF-I RECEPTOR HUMANIZED ANTIBODY
EP 3895732 A4申请人: TEIJIN PHARMA LTD优先权: 2018
CN
EP
US
WO
5 件公开
Humanized anti-VEGF antibody Fab fragment
US 12479911 B2申请人: SINOCELLTECH LTD优先权: 2019
CN
EP
US
WO
5 件公开
Humanized anti-human NKG2A monoclonal antibody
EP 2628753 A1申请人: NOVO NORDISK AS优先权: 2008
EP
US
5 件公开
Humanized anti-CD22 antibody
US 9139649 B2申请人: IMMUNOMEDICS INC优先权: 2014
CN
US
5 件公开